Wells Fargo’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.99M Sell
138,694
-61,051
-31% -$1.32M ﹤0.01% 2614
2025
Q1
$3.32M Sell
199,745
-2,604
-1% -$43.3K ﹤0.01% 2427
2024
Q4
$3.71M Buy
202,349
+14,447
+8% +$265K ﹤0.01% 2352
2024
Q3
$2.89M Buy
187,902
+2,185
+1% +$33.6K ﹤0.01% 2504
2024
Q2
$3.02M Buy
185,717
+83,797
+82% +$1.36M ﹤0.01% 2402
2024
Q1
$1.88M Buy
101,920
+13,721
+16% +$254K ﹤0.01% 2728
2023
Q4
$2.76M Sell
88,199
-55,921
-39% -$1.75M ﹤0.01% 2393
2023
Q3
$3M Sell
144,120
-42,837
-23% -$893K ﹤0.01% 2308
2023
Q2
$4.48M Buy
186,957
+7,730
+4% +$185K ﹤0.01% 2123
2023
Q1
$3.37M Buy
179,227
+78,190
+77% +$1.47M ﹤0.01% 2281
2022
Q4
$1.61M Sell
101,037
-2,164
-2% -$34.5K ﹤0.01% 2775
2022
Q3
$1.69M Sell
103,201
-585
-0.6% -$9.57K ﹤0.01% 2704
2022
Q2
$1.46M Sell
103,786
-61,757
-37% -$870K ﹤0.01% 2869
2022
Q1
$4.01M Sell
165,543
-38,915
-19% -$943K ﹤0.01% 2498
2021
Q4
$4.77M Buy
204,458
+8,271
+4% +$193K ﹤0.01% 2471
2021
Q3
$3.26M Buy
196,187
+37,796
+24% +$628K ﹤0.01% 3088
2021
Q2
$3.86M Buy
158,391
+3,588
+2% +$87.5K ﹤0.01% 2965
2021
Q1
$3.99M Sell
154,803
-22,244
-13% -$574K ﹤0.01% 2901
2020
Q4
$9.47M Sell
177,047
-24,481
-12% -$1.31M ﹤0.01% 2112
2020
Q3
$8.31M Sell
201,528
-16,273
-7% -$671K ﹤0.01% 2015
2020
Q2
$10.6M Sell
217,801
-12,260
-5% -$594K ﹤0.01% 1797
2020
Q1
$9.72M Buy
230,061
+19,666
+9% +$831K ﹤0.01% 1666
2019
Q4
$9M Buy
210,395
+3,646
+2% +$156K ﹤0.01% 2032
2019
Q3
$7.44M Buy
206,749
+7,584
+4% +$273K ﹤0.01% 2172
2019
Q2
$5.32M Buy
199,165
+30
+0% +$802 ﹤0.01% 2512
2019
Q1
$5.35M Buy
199,135
+3,866
+2% +$104K ﹤0.01% 2480
2018
Q4
$3.16M Buy
195,269
+11,265
+6% +$182K ﹤0.01% 2849
2018
Q3
$3.82M Sell
184,004
-95,313
-34% -$1.98M ﹤0.01% 2849
2018
Q2
$4.27M Buy
279,317
+94,853
+51% +$1.45M ﹤0.01% 2807
2018
Q1
$4.15M Buy
184,464
+36,951
+25% +$830K ﹤0.01% 2762
2017
Q4
$4.44M Sell
147,513
-25,297
-15% -$762K ﹤0.01% 2656
2017
Q3
$6.51M Sell
172,810
-2,558
-1% -$96.3K ﹤0.01% 2299
2017
Q2
$4.89M Buy
175,368
+39,480
+29% +$1.1M ﹤0.01% 2447
2017
Q1
$4.67M Buy
135,888
+9,608
+8% +$330K ﹤0.01% 2465
2016
Q4
$3.64M Buy
126,280
+66,772
+112% +$1.93M ﹤0.01% 2637
2016
Q3
$1.89M Sell
59,508
-76
-0.1% -$2.42K ﹤0.01% 2980
2016
Q2
$1.93M Sell
59,584
-18,893
-24% -$613K ﹤0.01% 2965
2016
Q1
$2.19M Buy
78,477
+4,055
+5% +$113K ﹤0.01% 2835
2015
Q4
$2.65M Sell
74,422
-1,318
-2% -$47K ﹤0.01% 2742
2015
Q3
$2.5M Buy
75,740
+25,306
+50% +$837K ﹤0.01% 2789
2015
Q2
$2.11M Buy
50,434
+17,446
+53% +$731K ﹤0.01% 3030
2015
Q1
$1.08M Sell
32,988
-25,094
-43% -$818K ﹤0.01% 3441
2014
Q4
$1.84M Sell
58,082
-504
-0.9% -$16K ﹤0.01% 3041
2014
Q3
$1.45M Sell
58,586
-15,682
-21% -$388K ﹤0.01% 3183
2014
Q2
$1.68M Buy
74,268
+6,502
+10% +$147K ﹤0.01% 3084
2014
Q1
$1.65M Buy
67,766
+3,287
+5% +$79.9K ﹤0.01% 3098
2013
Q4
$1.61M Buy
64,479
+41,703
+183% +$1.04M ﹤0.01% 3065
2013
Q3
$626K Buy
22,776
+9,236
+68% +$254K ﹤0.01% 3611
2013
Q2
$246K Buy
+13,540
New +$246K ﹤0.01% 4008